Security key
28176E108
Edwards Lifesciences Corp - Common Stock (EW)
CUSIP: 28176E108
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 490,550,647
- Total 13F value
- $45,304,945,713
- Share change
- +7,878,242
- Put/Call ratio
- 108%
- SEC-reported price per share
- $92.37
- Number of holders
- 1,277
- Value change
- +$713,718,504
- Number of buys
- 555
- Number of sells
- 548
- Shares outstanding
- 576,625,106
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
1,277
Top holders
10
EW full security history
Ownership snapshot
Full 13F holder table
Edwards Lifesciences Corp SEC filings
Edwards Lifesciences Corp company facts
Broader feeds
Ownership snapshot
Top reported holders of EW - Edwards Lifesciences Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 9.2%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 9.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
9.2%
BlackRock Finance, Inc.
9.1%
STATE STREET CORP
4.6%
Bank of New York Mellon Corp
3.3%
BROWN ADVISORY INC
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
9.2%
|
$5,061,277,490
52,964,394 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
9.1%
|
$5,009,216,784
52,419,598 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
4.6%
|
$2,558,694,015
26,775,785 shares
|
— | 31 Mar 2024 |
| Bank of New York Mellon Corp |
13F
Company
|
3.3%
|
$1,813,088,897
18,973,304 shares
|
— | 31 Mar 2024 |
| BROWN ADVISORY INC |
13F
Company
|
2.9%
|
$1,589,750,063
16,636,146 shares
|
— | 31 Mar 2024 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
2.8%
|
$1,567,731,654
16,405,731 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,277
Shares
490,550,647
Rows available
1,277
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
1,262
Q2 2024 holders
1,277
Holder diff
15
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|